Home›Sodium Hyaluronate, Lidocaine, Isopropyl Alcohol

Sodium Hyaluronate, Lidocaine, Isopropyl Alcohol

Also known as: Hyronan

Route: Epidural, Infiltration, Intra-Articular, Topical

Check Sodium Hyaluronate, Lidocaine, Isopropyl Alcohol Interactions →

4 interactions on record

Sodium Hyaluronate, Lidocaine, Isopropyl Alcohol has 4 known drug interactions based on U.S. FDA drug labeling data. 2 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Ergot-Type Oxytocic Drugs, Monoamine Oxidase Inhibitors (Maois), Butyrophenones. Patients taking Sodium Hyaluronate, Lidocaine, Isopropyl Alcohol should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.

Total: 4
Major: 2
Moderate: 2

Major (2)

Sodium Hyaluronate, Lidocaine, Isopropyl Alcohol + Ergot-Type Oxytocic Drugs— Concurrent administration of vasopressor drugs and ergot-type oxytocic drugs may cause severe, persistent hypertension o…
Sodium Hyaluronate, Lidocaine, Isopropyl Alcohol + Monoamine Oxidase Inhibitors (Maois)— Administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving MAOIs may pr…

Moderate (2)

Sodium Hyaluronate, Lidocaine, Isopropyl Alcohol + Butyrophenones— Butyrophenones may reduce or reverse the pressor effect of epinephrine. Concurrent use should generally be avoided; care…
Sodium Hyaluronate, Lidocaine, Isopropyl Alcohol + Phenothiazines— Phenothiazines may reduce or reverse the pressor effect of epinephrine. Concurrent use should generally be avoided; care…

Sodium Hyaluronate, Lidocaine, Isopropyl Alcohol + Ergot-Type Oxytocic Drugs⚠️Major

Concurrent administration of vasopressor drugs and ergot-type oxytocic drugs may cause severe, persistent hypertension or cerebrovascular accidents.

Sodium Hyaluronate, Lidocaine, Isopropyl Alcohol + Monoamine Oxidase Inhibitors (Maois)⚠️Major

Administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving MAOIs may produce severe, prolonged hypertension.

Sodium Hyaluronate, Lidocaine, Isopropyl Alcohol + Butyrophenones🟡Moderate

Butyrophenones may reduce or reverse the pressor effect of epinephrine. Concurrent use should generally be avoided; careful patient monitoring is essential if necessary.

Sodium Hyaluronate, Lidocaine, Isopropyl Alcohol + Phenothiazines🟡Moderate

Phenothiazines may reduce or reverse the pressor effect of epinephrine. Concurrent use should generally be avoided; careful patient monitoring is essential if necessary.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.